first approval for epanolol (‘visacor’)
TRANSCRIPT
22 MARKET NEWS
First approval for epanolol ('Visacor') ICI's beta blocker, epanolol, (Visacor) has
received its first approval, in Belgium. Epanolol is a once-<iaily antianginal which combines selective beta-I blockade with beta-l selective partial agonist activity. The drug was developed for an adverse effect profile which is more tolerable than full beta blockers.
ICI are reported to be looking for a licensee to market'Visacor'. .."
ISSNOl56-2703/92/0229-0022/$1.00/0© Adis Inl.mClIiClIIClllid